Laila König, Henrik Hauswald, Christa Flechtenmacher, Martina Heller, Uwe Haberkorn, Frederik Giesel
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)
10.1016/j.oraloncology.2011.04.020 · 2011
Adenoid cystic carcinoma of the head and neck: a review
10.1097/00020840-200404000-00013 · 2004
Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies
10.1016/j.oraloncology.2006.01.001 · 2006
Adenoid cystic carcinoma of the head and neck–An update
10.1016/j.oraloncology.2015.04.005 · 2015
Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands
10.1016/s0901-5027(97)80008-2 · 1997
Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology
10.1002/hed.21706 · 2012
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
10.1016/s1470-2045(10)70245-x · 2011
The more important heavy charged particle radiotherapy of the future is more likely to be with heavy ions rather than protons
10.1118/1.4798945 · 2013
Proton vs carbon ion beams in the definitive radiation treatment of cancer patients
10.1016/j.radonc.2010.01.015 · 2010
Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1002/cncr.29443 · 2015
High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years’ experience with raster-scanned carbon ion therapy
10.1016/j.radonc.2015.05.010 · 2016
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
10.1002/jcb.10661 · 2004
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
10.1007/s00259-012-2298-2 · 2013
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
10.1007/s00259-012-2069-0 · 2012
Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique
10.1111/j.1365-2559.2007.02635.x · 2007
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
10.1038/modpathol.2012.66 · 2012
Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
10.1186/1475-2867-14-26 · 2014
Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance
10.1371/journal.pone.0125924 · 2015
In Vivo visualization of prostate-specific membrane antigen in adenoid cystic carcinoma of the salivary gland
10.1097/rlu.0000000000001220 · 2016
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
10.1007/s00259-017-3737-x · 2017
No additional external references are available.
